Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs INCY✓SelectedUSD · INCYGSK vs INCY performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs INCY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.1%
INCY return
+118.7%
Excess return
-61.6%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioINCYExcessAlpha
1D-2.3%-1.0%-1.3%-2.1%
7D-3.0%-1.0%-2.0%-2.8%
30D+0.4%+5.3%-5.0%-0.8%
3M-1.2%-3.6%+2.4%-0.5%
6M+0.9%+25.0%-24.0%-3.4%
YTD+4.0%+20.6%-16.6%-0.1%
1Y+7.3%+14.3%-7.0%+3.9%
3Y+57.1%+119.4%-62.4%+37.0%
All+57.1%+118.7%-61.6%+37.0%

Cumulative growth

Daily Returns

Daily percentage return beside INCY.

Daily Out/Under-Performance

Portfolio return minus INCY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × INCY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded INCY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling